How's this baby gonna work? And then so I sit with. We have this amazing meeting with Bobby Kennedy and. And his team, and we say, look, I've got these 232 tariffs. I could smash these companies. Smash them, because they all make it overseas and then export it to us. And we're. And we're all the money. So we could charge them any tariff we want. We charge them 500%. So let's do something that's never been done before. (46:56–47:05)
CLAIM
Asserts that Section 232 tariffs could be used to heavily impact pharmaceutical companies.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.